GlassScriptPhysician profile
Jawad Haider
NPI 1194773564
$43,996.97
in general payments reported to CMS, 2019-2025
41 companies · $3,048 in 2025
The $3,048 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,243 · 2020: $17K · 2021: $5,344 · 2022: $3,561 · 2023: $5,421 · 2024: $5,264 · 2025: $3,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,821 · Travel and Lodging: $3,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,821.22 |
| Travel and Lodging | $3,912.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18,617.13 | 2019-2025 | Farxiga |
| Abbott Laboratories | $6,859.45 | 2019-2025 | Mitraclip, Cardiomems, Amplatzer Amulet |
| Boston Scientific Corporation | $5,606.28 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Edwards Lifesciences Corporation | $5,116.90 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,427.07 | 2021-2025 | Corevalve Evolut R, Apollotm, Symplicity G3 |
| Baylis Medical Company INC | $1,024.27 | 2021 | |
| Medical Device Business Services, INC. | $682.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $539.97 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $451.16 | 2019-2025 | |
| Amgen INC. | $361.86 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $346.71 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.67 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $244.49 | 2025 | |
| Amarin Pharma, INC. | $239.54 | 2019-2023 | |
| Medtronic Vascular, INC. | $236.17 | 2019-2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jawad Haider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.